Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAPAS PK study of once-daily inhaled tobramycin in adults with cystic fibrosis
NL-OMON40371Active, not recruiting
- Sponsor
- HagaZiekenhuis
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of tobramycin in cystic fibrosis (CF) and Pseudomonal infection (2 arms), sponsored by HagaZiekenhuis. Primary endpoint: Systemic bioavailability of inhaled tobramycin. Started Mar 2014; status: active, not recruiting.
02
Drugs
tobramycin
03
Conditions
cystic fibrosis (CF)Pseudomonal infection
Beyond the preview
Go deeper on NL-OMON40371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40371.